Ignacio Wistuba Selected Research

Ignacio Wistuba Research Topics

Disease

58	Neoplasms (Cancer) 05/2022 - 08/2004
24	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2006
17	Lung Neoplasms (Lung Cancer) 01/2020 - 08/2010
11	Adenocarcinoma of Lung 05/2022 - 04/2008
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2021 - 04/2017
5	Adenocarcinoma 01/2015 - 04/2006
4	Carcinoma (Carcinomatosis) 01/2022 - 04/2007
3	Neoplasm Metastasis (Metastasis) 05/2022 - 10/2010
3	Inflammation (Inflammations) 07/2021 - 04/2006
3	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 02/2011
3	Malignant Mesothelioma 06/2014 - 10/2009
2	Mouth Neoplasms (Oral Cancer) 01/2019 - 11/2009
2	Mesothelioma 06/2014 - 04/2009
2	Mucinous Adenocarcinoma (Mucinous Carcinoma) 05/2013 - 02/2011
2	Carcinogenesis 04/2008 - 04/2006
1	Cholangiocarcinoma 01/2022
1	Febrile Neutropenia 11/2020
1	Osteosarcoma (Osteogenic Sarcoma) 01/2020
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2019
1	Glioma (Gliomas) 10/2018
1	Hyperplasia 10/2017
1	Ovarian Neoplasms (Ovarian Cancer) 04/2017

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 07/2021 - 11/2012
9	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2007
6	Tyrosine Kinase InhibitorsIBA 03/2018 - 08/2010
6	ErbB Receptors (EGF Receptor)IBA 11/2017 - 03/2006
5	DNA (Deoxyribonucleic Acid)IBA 05/2019 - 12/2008
4	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
4	Biological ProductsIBA 10/2018 - 07/2004
3	EnzymesIBA 05/2022 - 07/2021
3	B7-H1 AntigenIBA 01/2022 - 10/2018
3	AntibodiesIBA 01/2022 - 01/2019
3	Pemetrexed (MTA)FDA Link 01/2022 - 02/2011
3	NivolumabIBA 01/2022 - 01/2019
3	Circulating Tumor DNAIBA 10/2021 - 01/2018
3	Indicators and Reagents (Reagents)IBA 01/2021 - 01/2015
3	Formaldehyde (Formol)FDA Link 01/2021 - 01/2015
3	theasinensin AIBA 01/2021 - 09/2015
3	ParaffinIBA 01/2021 - 01/2015
3	Messenger RNA (mRNA)IBA 10/2019 - 09/2014
3	Phosphotransferases (Kinase)IBA 11/2017 - 05/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 09/2014 - 11/2012
3	Sorafenib (BAY 43-9006)FDA Link 12/2013 - 11/2012
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2009 - 07/2007
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2022 - 11/2021
2	liquid crystal polymerIBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 01/2022 - 01/2019
2	Phenobarbital (Luminal)FDA Link 07/2021 - 01/2020
2	Histone Deacetylases (Histone Deacetylase)IBA 10/2019 - 09/2015
2	pyrimidineIBA 05/2019 - 01/2017
2	Thyroid Nuclear Factor 1IBA 01/2019 - 05/2013
2	LigandsIBA 10/2017 - 04/2006
2	Cisplatin (Platino)FDA LinkGeneric 04/2017 - 05/2014
2	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 01/2017
2	MucinsIBA 05/2013 - 02/2011
2	vandetanib (ZD6474)IBA 05/2013 - 11/2012
2	Colloids (Colloid)IBA 05/2013 - 02/2011
2	Bexarotene (LGD1069)FDA Link 05/2013 - 11/2012
2	Dasatinib (BMS 354825)FDA Link 05/2012 - 10/2010
1	KynurenineIBA 05/2022
1	Tryptophan (L-Tryptophan)FDA Link 05/2022
1	kynureninaseIBA 05/2022
1	Folic Acid AntagonistsIBA 01/2022
1	urelumabIBA 01/2022
1	5'-methylthioadenosine phosphorylase (methylthioadenosine nucleosidase)IBA 01/2022
1	purineIBA 01/2022
1	Programmed Cell Death 1 ReceptorIBA 01/2022
1	Protein Subunit VaccinesIBA 01/2022
1	Adenine FDA LinkGeneric 01/2022
1	Interferon Type IIBA 01/2022
1	Interleukin-2 (IL2)IBA 01/2022
1	InterleukinsIBA 01/2022
1	Keratins (Keratin)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 11/2021
1	Adenosine (Adenocard)FDA LinkGeneric 07/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2020
1	Carboplatin (JM8)FDA LinkGeneric 11/2020
1	Lipase (Acid Lipase)FDA Link 11/2020
1	pembrolizumabIBA 01/2020
1	Enhancer of Zeste Homolog 2 ProteinIBA 10/2019
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2019
1	VaccinesIBA 01/2019
1	atezolizumabIBA 10/2018
1	Immunoglobulins (Immunoglobulin)IBA 10/2018
1	Mucin-3IBA 10/2018
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2018
1	VimentinIBA 01/2018
1	Hormones (Hormone)IBA 11/2017
1	Interleukin-6 (Interleukin 6)IBA 11/2017
1	HhAntag691IBA 11/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2017

Therapy/Procedure

18	Therapeutics 05/2022 - 04/2009
3	Immunotherapy 01/2022 - 01/2021
3	Neoadjuvant Therapy 11/2020 - 01/2020
2	Adjuvant Chemotherapy 01/2015 - 08/2004
1	Precision Medicine 10/2021
1	Aftercare (After-Treatment) 10/2018